Satoshi Watanabe1, Shoichiro Kameoka1, Natsuko O Shinozaki1, Ryuichi Kubo1, Akifumi Nishida1,2,3, Minoru Kuriyama1, Aya K Takeda1. 1. Cykinso, Inc., 1-36-1 Yoyogi, Shibuya, Tokyo 151-0053, Japan. 2. Department of Electrical Engineering and Bioscience, Waseda University, 1-104 Totsuka, Shinjuku-ku, Tokyo 169-8050, Japan. 3. School of Computing, Tokyo Institute of Technology, 2-12-1 Okayama, Meguro-ku, Tokyo 152-8550, Japan.
Since the establishment of next-generation 16S rRNA sequencing analysis, multiple large
cohort studies focusing on the humangut microbiome have been conducted, such as the US
Human Microbiome Project [1] and MetaHIT in Europe
[2]. An integrated catalog of human fecal microbial
metagenomes from 1,200 people in the United States, China, and Europe has identified 9.9
million microbial genes across fecal microbiota [3].
However, studies on gut microbiome from Japanese populations are scarce, especially those
reporting on healthy or non-diseased individuals. Further, in recent studies comparing gut
microbiomes by race/nationality, clear impacts of dietary habits were demonstrated [4], suggesting that, owing to the unique Japanese food
culture, the gut of Japanese individuals could harbor different flora from those of
individuals in western countries. Therefore, to advance research on the gut microbiome and
various diseases in Japan, it is critical to characterize the healthy gut microbiome in the
Japanese population.Host parameters such as age, gender, and body mass index (BMI) have been reported to be
related to individual differences in gut microbiota composition [5,6,7,8,9]. Further, differences in dietary habits have been shown to affect the bacterial
diversity and enterotype of human gut microbiota [10,
11], which may partially explain why differences in
residential areas/countries are strongly associated with differences in gut microbiota
composition [12, 13].Recently, several studies have revealed gender differences in gut microbiota [14,15,16,17]. For
instance, Min et al. [18] conducted
an association study to identify bacterial compositions associated with men and women, and
showed similar microbiota characteristics, including overall abundance and diversity,
between men and women. However, they also showed gender differences at the species level
between microbial taxa related to fat distribution, suggesting the existence of a
gender-specific microbiome signature corresponding to gender-specific fat distribution,
which may also contribute to the observed sex-specific immunity differences [19]. Thus, several immune pathophysiologies may be
involved in gender differences in gut bacterial composition.Age is also an important factor affecting the gut microbiota [8, 20,21,22,23]. Recent reports have described differences in gut microbiota between
children and adults, and an adult-like composition of bacterial communities is established
at around 3–4 years of age or older [7, 20, 24,25,26]. In
addition, the intestinal microbiota has been shown to change with age, although the
definition of old age has differed between reports and include individuals older than 60,
65, 70, or 100 years [14, 27,28,29]. The associated mechanism also remains unknown. Yatsunenko et
al. [8] conducted a large study of subjects
aged 0–83 years and showed continuous changes that occurred with age. They found that the
period required to form an adult-like gut microbiota was the 3-year period following birth.
Second, interpersonal variation was significantly greater between children than between
adults. Third, the dominance of Bifidobacterium in the baby microbiota
continued throughout the first year of life, although this dominance diminished with age.
Nevertheless, owing to the limited number of subjects over 60 years of age, the specific
continuous changes that occur in older people remain unknown. Recently, Odamaki et
al. [7] reported age-related compositional
differences from infants to centenarians in a Japanese cross-sectional study. They found
that Bifidobacterium decreased and Enterobacteriaceae increased with age,
as observed in some previous studies [8, 21,22,23].Relationships have also been observed between gut microbiota and diarrhea/constipation.
Vandeputte et al. [30] described an
association between stool consistency and gut microbiota composition in 53 healthy female
subjects. Tigchelaar et al. [31]
also reported an association between stool consistency and the structure of gut microbiota.
Hadizadeh et al. [32] demonstrated a
correlation between the number of bowel movements and gut microbiota. In a Japanese cohort,
Takagi et al. [33] reported
significant differences in microbial structure between individuals with differences in stool
consistency (Bristol stool scale type). Therefore, investigating the relationship between
bowel habits and intestinal bacterial composition can provide important information on
gastrointestinal motility function.However, Japan has its own food culture and customs compared to western countries, and the
intestinal flora of Japanese individuals contain more genes for polysaccharide-degrading
enzymes derived from water-soluble dietary fiber than Americans [34]. This feature may be related to the longer life expectancy of
Japanese people and their low BMIs [35, 36]. Nishijima et al. [37] clearly showed significant differences in the gut
microbiota of the Japanese population compared to other countries, which cannot be explained
by meals alone. Therefore, the structure of the intestinal flora may be highly dependent on
an individual’s country/region and lifestyle [38].In this study, we investigated the relative abundance ranges of microbial taxa in stool
samples from a large healthy human cohort. Further, we analyzed the relationship between the
aforementioned genera or gut microbiota composition and Japanese demographic features,
lifestyle, and bowel habits. Finally, we developed reference ranges using a large healthy
Japanese cohort and considered the effects of age, gender, diarrhea, and constipation.
MATERIALS AND METHODS
Study design and participants
From November 2015 through June 2019, a Mykinso cohort of 5,843 individuals who had
submitted fecal samples (one sample per subject) was selected from data obtained through
the Mykinso gut microbiome testing service. Informed consent was obtained from all
participants in the study. All procedures complied with the principles of the Declaration
of Helsinki and were approved by the Institutional Review Board (IRB) at our institution,
and the study was registered as UMIN000028887 and UMIN000028888 in the UMIN Clinical
Trials Registry System. The IRB-approved protocol specifically allows for a study
involving a cross-sectional (one time per subject) analysis of the survey data and
subsequent follow-up survey (multiple times per subject). In this study, we analyzed only
cross-sectional data from the cohort study dataset.
Demographic features, bowel habits, and disease and medication data
Using an original survey (Supplementary Table 1), metadata were collected through the
Mykinso gut microbiome testing service. The original survey included questions on
demographic features, lifestyle, bowel habits, and disease. Individuals were scored
positive for a disease if they replied yes to any original survey question, negative if
they replied no, and unknown if data were unavailable across all original surveys.
Fecal sampling, DNA extraction, and sequencing
Fecal samples were collected using brush-type collection kits containing guanidine
thiocyanate solution (Techno Suruga Laboratory, Shizuoka, Japan), transported at normal
temperature, and stored at 4°C. DNA extraction from the fecal samples was performed using
an automated DNA extraction system (GENE PREP STAR PI-480, Kurabo Industries Ltd, Osaka,
Japan) according to the manufacturer’s protocol. The V1–V2 region of the 16S rRNA gene was
amplified using a forward primer (16S_27Fmod: TCG TCG GCA GCG TCA GAT GTG TAT AAG AGA CAG
AGR GTT TGA TYM TGG CTC AG) and a reverse primer (16S_338R: GTC TCG TGG GCT CGG AGA TGT
GTA TAA GAG ACA GTG CTG CCT CCC GTA GGA GT) and KAPA HiFi HotStart ReadyMix (Roche). To
sequence 16S amplicons by Illumina MiSeq platform, dual index adapters were attached using
the Nextera XT Index kit. Each library was diluted to 5 ng/µL, and equal volumes of the
libraries were mixed to 4 nM. The DNA concentration of the mixed libraries was quantified
by qPCR with KAPA SYBR FAST qPCR Master Mix (KK4601, KAPA Biosystems) using primer 1 (AAT
GAT ACG GCG ACC ACC) and primer 2 (CAA GCA GAA GAC GGC ATA CGA). The library preparations
were carried out according to 16S library preparation protocol of Illumina (Illumina, San
Diego, CA, USA). Libraries were sequenced using the MiSeq Reagent Kit v2 (500 Cycles), to
produce 250 bp paired-end reads.
Taxonomy assignment based on 16S rRNA gene sequences
Paired-end reads of partial 16S rRNA gene sequences were clustered by 97% nucleotide
identity and then assigned taxonomic information using the Greengenes database (v13.8)
[39] through the QIIME pipeline (v1.8.0) [40]. The steps for data processing and assignment based
on the QIIME pipeline were as follows: (i) joining paired-end reads; (ii) quality
filtering with an accuracy of Q30 (>99.9%) and a read length > 300 bp; (iii)
randomly extracting 10,000 reads per sample for subsequent analysis; (iv) clustering
operational taxonomic units (OTUs) with 97% identity by UCLUST (v1.2.22q) [41]; and (v) assigning taxonomic information to each
OTU using the RDP classifier [42] with the
full-length 16S gene data of Greengenes (v13.8) to determine the identity and composition
of bacterial genera.
Transformation of compositional microbiome data for hypothesis testing
Centered log-ratio (clr) transformed values were used as inputs for multivariate
hypothesis testing [43] to manage 0 count values as
both point estimates using the zCompositions R package [44] and as a probability distribution using the ALDEx2 package [45] available on Bioconductor.
Group differences in beta-diversity
Aitchison distance, the Euclidian distance between samples after clr transformation, and
the distances between samples are the same as the phylogenetic ilr [43]. Replacement for β-diversity exploration of microbiome data is a
variance-based compositional principal component (PCA) biplot [46], in which the relationship between inter-OTU variance and sample
distance can be observed [47]. Compositional PCA
biplots display the relationships between OTUs and distances between samples on a common
plot to glean substantial and qualitative information regarding dataset quality and the
relationships between groups [47].
Group differences in alpha-diversity
Microbiota diversity was assessed by the Shannon index based on 97% nucleotide sequence
identity. These values were calculated using QIIME [40] with a depth of 10,000 reads. To test two-group differences between male and
female groups, we calculated p values using the two-sided unpaired Welch’s t-test. To test
group differences among age groups in the diversity index, we calculated p values using
one-way analysis of variance (ANOVA).
Group differences in taxonomic abundance
To compare the taxonomic abundance between the groups, we conducted the univariate
statistical test using the ALDEx2 tool. The false discovery rate (FDR) control was
performed based on the Benjamini-Hochberg procedure to correct for multiple testing, i.e.,
‘p.adjust’ in R. Analysis was confined to taxa with a prevalence greater than 10% and a
maximum proportion (relative abundance) greater than 0.005. An FDR-adjusted p-value less
than 5% was considered to be significant.
RESULTS
Cohort characteristics
The participants primarily resided in Japan (n=5,843; Supplementary Table 2) and were
characterized by a greater range in age, stool type, and lifestyle than the participants
in other Japanese large-scale microbiome projects [7, 33, 37]. In the original survey, participants (n=4,479) reported demographic
features, disease history, and lifestyle data (participants missing any of these data were
excluded; Supplementary Table 3). In accordance with our IRB, all survey questions were
optional (question response rate, 76.65%). Eligible subjects were male and female who were
considered to not have disease history (ineligible subjects were those who self-reported
any disease history; Supplementary Table 4). Eligible criteria included no self-reported
history of any disease. Ultimately, 2,865 individuals were included in the subsequent
analysis (Table 1, Supplementary Fig.
1).
Table 1.
Distribution of primary eligible subjects
Demographicfeatures
Female
Male
Number of samples
1,722
1,143
BMI
21.1 (3.0)
23.1 (3.5)
Age
40.16 (11.30)
41.77 (11.30)
Age group
19 and under
20 (1.2%)
10 (0.9%)
20–29
322 (18.7%)
135 (11.8%)
30–39
559 (32.5%)
408 (35.7%)
40–49
485 (28.2%)
358 (31.3%)
50–59
249 (14.5%)
159 (13.9%)
60–69
73 (4.2%)
52 (4.5%)
70 and over
14 (0.8%)
21 (1.8%)
Mean (SD); n/N (%).
BMI: Body Mass Index.
Mean (SD); n/N (%).BMI: Body Mass Index.
Sex-related gut microbiota
Taxonomic differences in microbial communities were evaluated at the genus level. The
comparison of microbial composition between male and female subjects showed a significant
richness in the abundances of 12 and 13 genera in male and female subjects, respectively
(blue and red points, respectively, in Fig.
1). The results were characterized by a richness in the representative genera
Prevotella, Megamonas, Collinsella,
Dorea, Megasphaera, and Fusobacterium
(p<0.001, FDR-adjusted p-value<0.005) in male subjects and an increase in
representative genera Oscillospira, Coprobacillus,
Ruminococcus, Bacteroides,
Eggerthella, Anaerotruncus,
Trabulsiella, and Akkermansia (p<0.001,
FDR-adjusted p-value <0.005) in female subjects. Subsequently, we evaluated the
alpha-diversity of gut microbiota using the Shannon index. The Shannon index showed no
statistically significant differences between male (mean=6.013) and female (mean=6.008)
subjects (Welch’s two-sample t-test; t (2,352.5) =−0.198, p=0.843, 95% CI
=−0.049 to 0.060). Next, the dissimilarity of the overall structure of the gut microbiome
for male and female subjects, beta-diversity was calculated using Aitchison distance
(Fig. 2). PCA revealed that there were structural differences between male and female
subjects (PERMANOVA, R2=0.060, p=0.001).
Fig. 1.
Relative abundances of gut microbiota in male and female subjects. Genera were
significantly different between male and female subjects. diff_btw = median
difference in clr values between female and male groups. magenta: positive diff_btw
in female group; cyan: negative diff_btw in female group.
Fig. 2.
Plot of individual samples from PCA output (magenta: female samples, cyan: male
samples). The distance between points is proportional to the Euclidian distance of
CLR vectors of the samples (Aitchison distance). The multivariate distance between
samples was estimated using the Aitchison distance, which showed significantly
different composition between female and male samples (ANOSIM,
R=0.060, p=0.001).
Relative abundances of gut microbiota in male and female subjects. Genera were
significantly different between male and female subjects. diff_btw = median
difference in clr values between female and male groups. magenta: positive diff_btw
in female group; cyan: negative diff_btw in female group.Plot of individual samples from PCA output (magenta: female samples, cyan: male
samples). The distance between points is proportional to the Euclidian distance of
CLR vectors of the samples (Aitchison distance). The multivariate distance between
samples was estimated using the Aitchison distance, which showed significantly
different composition between female and male samples (ANOSIM,
R=0.060, p=0.001).
Age-related gut microbiota
Further, differences in the gut microbial structure in each age group were taxonomically
evaluated at the phylum level (Fig. 3). In agreement with previous results, the microbiota composition included four
predominant phyla (Firmicutes, Bacteroidetes, Actinobacteria, and Proteobacteria). Of
these, Actinobacteria showed a trend to decrease in the 60 years old group (p=0.040,
FDR-adjusted p-value=0.640) and 70 years or older group (p=0.048, FDR-adjusted
p-value=0.700), compared to the 19 years or under group. The alpha-diversity index showed
significant differences across age groups in our cohort (ANOVA; F(6,2851)
= 5.045, p<0.001; Fig. 4). We also tested the multiplicity correction of each pair difference with the
Benjamini & Hochberg method, and statistically significant differences were found
between 20s and 60s age groups (p<0.001), between 30s and 60s age groups (p=0.008),
between 20s and 40s age group (p=0.006), and between 50s and 60s age groups
(p=0.043;Table 2). Additionally, we created three age groups (young group,
0–19; adult group, 20–59; and elderly group, 60 years or older), and the overall structure
of the gut microbiome using beta-diversity indices was calculated using Aitchison distance
(Fig. 5). PCA revealed that there were microbial structural differences among the three age
groups (PERMANOVA, R2=0.034, p<0.001).
Fig. 3.
Comparative analyses of the taxonomic composition of the microbial community at the
phylum level for each age group. Each component of the cumulative bar chart
indicates a phylum.
Fig. 4.
Age-related differences in the Shannon index of gut microbiota.
Table 2.
Pairwise comparisons of the Shannon index between age groups
Age-group pair
diff
lwr
upr
p.adj
20s–19under
0.001
−0.398
0.400
1.000
30s–19under
0.109
−0.284
0.502
0.983
30s–20s
0.108
−0.012
0.228
0.112
40s–19under
0.151
−0.242
0.545
0.917
40s–20s
0.151
0.027
0.274
0.006
40s–30s
0.043
−0.057
0.142
0.870
50s–19under
0.128
−0.272
0.529
0.965
50s–20s
0.127
−0.017
0.272
0.125
50s–30s
0.019
−0.106
0.145
0.999
50s–40s
−0.023
−0.151
0.105
0.998
60s–19under
0.349
−0.082
0.779
0.203
60s–20s
0.348
0.134
0.562
<0.001
60s–30s
0.240
0.039
0.441
0.008
60s–40s
0.197
−0.006
0.400
0.063
60s–50s
0.220
0.004
0.437
0.043
70over–19under
0.303
−0.224
0.830
0.618
70over–20s
0.302
−0.069
0.674
0.199
70over–30s
0.194
−0.170
0.559
0.701
70over–40s
0.152
−0.214
0.517
0.885
70over–50s
0.175
−0.198
0.548
0.812
70over–60s
−0.046
−0.451
0.359
1.000
diff: Differences in mean levels; lwr: 95% confidence lower level; upr: 95%
confidence upper level
p.adj: p-value adjusted by Benjamin & Hochberg medhods.
Fig. 5.
(a) Plot of individual samples from PCA output (red: elderly samples, blue: young
samples, and gray: adult samples). The distance between points is proportional to
the Euclidian distance of CLR vectors of the samples (Aitchison distance). (b) The
multivariate distance between samples was estimated using the Aitchison distance,
which showed significantly different compositions in the junior, adult and senior
samples (red: elderly r, blue: young, and gray: adult) (PERMANOVA,
R2=0.034, p<0.001).
Comparative analyses of the taxonomic composition of the microbial community at the
phylum level for each age group. Each component of the cumulative bar chart
indicates a phylum.Age-related differences in the Shannon index of gut microbiota.diff: Differences in mean levels; lwr: 95% confidence lower level; upr: 95%
confidence upper levelp.adj: p-value adjusted by Benjamin & Hochberg medhods.(a) Plot of individual samples from PCA output (red: elderly samples, blue: young
samples, and gray: adult samples). The distance between points is proportional to
the Euclidian distance of CLR vectors of the samples (Aitchison distance). (b) The
multivariate distance between samples was estimated using the Aitchison distance,
which showed significantly different compositions in the junior, adult and senior
samples (red: elderly r, blue: young, and gray: adult) (PERMANOVA,
R2=0.034, p<0.001).
Bowel habits-related gut microbiota
Considering the heterogeneity and varying generations of samples in this dataset, we
excluded samples from the young (0–19) and elderly (60 years or older) groups, which might
have caused bias in the subsequent analysis [7,
14, 27,28,29]. As a result, 2,675 samples were included in the resulting dataset (Table 3, Supplementary Fig.
1). The bowel habits (stool shape and defecation frequency) of all participants
enrolled in this study were recorded and classified using the self-reported original
survey. Additionally, perceived symptoms of diarrhea/constipation were recorded and
classified. According to the stool shape, bowel frequency, and perceived symptom scores,
participants were classified as normal bowel habit type, diarrhea type, constipation type,
or mixed type. Participants reporting stool type 1 (hard stool), defecation frequency type
4 (less than once per week), or frequent perception of constipation symptoms within 1
month were classified into the constipation type. Participants reporting stool type 7
(liquid stools), defecation frequency type 1 (more than three times per day), or frequent
perception of diarrhea symptoms within 1 month were classified as the diarrhea type.
Finally participants who fit into both the constipation and the diarrhea types were
classified into the mixed type. The constipation group (female, n=337, 20.87%; male, n=37,
3.49%), diarrhea group (female, n=357, 22.11%; male, n=457, 43.11%), mixed group (female,
n=139, 8.61%; male, n=29, 2.74%), and normal group (female, n=782, 48.42%; male, n=537,
50.66%) were observed (Table 3). Importantly,
the Shannon index for each bowel habit group showed a significant difference among groups
in our cohort (ANOVA; F(3,2667)=1.761, p<0.001; Fig. 6). We also tested each pair difference with the Benjamini & Hochberg method,
which showed statistically significant differences between the normal and diarrhea groups
(p<0.001), constipation and diarrhea groups (p<0.001), and mixed and diarrhea groups
(p=0.001). These differences are illustrated in Fig.
6. Additionally, the beta-diversity indices among the four bowel habit groups
using was calculated using Aitchison distance and visualized by PCA according to Aitchison
distance (Fig. 7). An additional PERMANOVA analysis showed that the bowel habit type was a
significant factor contributing to the variation of the structure of the gut microbiota
(p<0.001). Approximately 0.7% of the variance in beta-diversity was explained by the
bowel habit type (PERMANOVA; F(3,2667)=6.714,
R2=0.007, p<0.001), which was competitive with available
measurements for clinical and environmental covariates. Subsequently, at the genus level,
we identified several altered bacteria among the four bowel habit groups. Interestingly, a
significantly higher relative abundances of Fusobacterium (p<0.001,
FDR-adjusted p-value<0.005) and Oscillospira (p<0.001, FDR-adjusted
p-value<0.005) were observed in the diarrhea and constipation groups, respectively. In
addition, the relative abundances of Ruminococcus,
Anaerotruncus, Alistipes, and
Akkermansia (p<0.01, FDR-adjusted p-value<0.05) were
significantly higher in the constipation group, whereas that of Dorea
(p<0.01, FDR-adjusted p-value<0.05) was higher in the diarrhea group.
Table 3.
Distribution of bowel habits by sex and age group (20–50)
Age-group: gender
Normal stool
Diarrhea
Constipation
Mixed
Number of samples
20–29: male
59
69
2
5
135
20–29: female
149
76
57
40
322
30–39: male
196
185
14
13
408
30–39: female
243
134
128
54
559
40–49: male
185
150
15
8
358
40–49: female
233
112
111
29
485
50–59: male
97
53
6
3
159
50–59: female
157
35
41
16
249
Sum
1,319
814
374
168
2,675
Fig. 6.
Alteration of the Shannon index of gut microbiota associated with stool
consistency. Comparison of α-diversity indices: Shannon index (OTU evenness
estimation). Bowel habit was categorized into four groups: normal, diarrhea,
constipation, and mixed.
Fig. 7.
(a) Plot of individual samples from PCA output (gray: normal samples, red: diarrhea
samples, green: constipation samples, and blue: mixed type samples). The distance
between points is proportional to the Euclidian distance of CLR vectors of the
samples (Aitchison distance). The multivariate distance between samples was
estimated using the Aitchison distance, which showed significantly different
compositions between the bowel habit type (PERMANOVA,
R2=0.007, p<0.001). (b) RDA triplot of CLR vectors of
the samples constrained by bowel habit group.
Alteration of the Shannon index of gut microbiota associated with stool
consistency. Comparison of α-diversity indices: Shannon index (OTU evenness
estimation). Bowel habit was categorized into four groups: normal, diarrhea,
constipation, and mixed.(a) Plot of individual samples from PCA output (gray: normal samples, red: diarrhea
samples, green: constipation samples, and blue: mixed type samples). The distance
between points is proportional to the Euclidian distance of CLR vectors of the
samples (Aitchison distance). The multivariate distance between samples was
estimated using the Aitchison distance, which showed significantly different
compositions between the bowel habit type (PERMANOVA,
R2=0.007, p<0.001). (b) RDA triplot of CLR vectors of
the samples constrained by bowel habit group.
Reference ranges from the healthy Japanese cohort
Considering the heterogeneity and bowel habits of the sample dataset, we excluded samples
from individuals with diarrhea or constipation (Supplementary Fig. 1), which might cause
bias in reference ranges [30,31,32,33]. Ultimately, 1,319 samples were selected as a healthy reference
dataset (Supplementary Fig. 1). We identified 453 genera and 20 phyla of Bacteria and
Archaea in the gut microbiomes of the healthy reference dataset. The genera with an
average relative abundance of ≥ 0.5% in the Japanese healthy reference dataset are listed
in Supplementary Fig. 2. At the genus level, the Japanese healthy reference was
characterized by the highest abundances of Bacteroides,
Faecalibacterium, Prevotella,
Blautia, Bifidobacterium, Coprococcus,
and Parabacteroides (Supplementary Fig. 2).In this study, health-related microbiome indices were selected based on peer-reviewed
studies in academic journals and in-house data analyses (Table 4). To determine the reference ranges of 11 target microbiome indices, the
dataset of 1,319 individuals selected from the Mykinso cohort as described above was
established. Microbiome data from this dataset were analyzed to determine the empirical
reference ranges for two indices of overall community structure, two complex genus
indices, one class, and six genera. For each of the 1,319 samples, we determined the
relative abundance of each target within the microbial population, revealing the
distribution of the relative abundance of each target in the cohort (Table 4). These data were used to define a central 80% healthy
range with confidence intervals for each target. Many of the targets show significant
spread, highlighting the importance of defining reference ranges for health-related
indices.
Table 4.
Reference ranges from healthy Japanese subjects for 11 clinically relevant
indices
Microbiome Index
unit
group
lower limit[10%]
median [50%]
upper limit [90%]
Reference
Shannon
value
all
5.08
6.01
6.88
[58, 59]
male
5.15
6.03
6.93
female
5.05
6
6.85
Observed genera
genus
all
54
65
80
[58, 59]
male
54
65
81
female
54
66
79
Bifidobacterium
%
all
0.18
2.47
9.6
[60, 61]
male
0.12
2.18
8.45
female
0.21
2.79
10.41
Faecalibacterium
%
all
0.55
6.83
12.87
[62]
male
0.37
6.36
12.09
female
0.57
7.23
13.27
Butyric acid-producing genera group
*1
%
all
4.25
12.16
20.47
[59]
male
3.64
11.53
20.03
female
4.66
12.88
20.89
Clostridium
%
all
0
0.19
0.79
[59]
male
0
0.19
0.7
female
0
0.2
0.89
Lactobacillales genera
group verified lactic acid producers *2
%
all
0
0.01
0.22
[59, 63]
male
0
0.01
0.24
female
0
0.01
0.21
Streptococcus
%
all
0.05
0.38
2.58
[63, 65]
male
0.03
0.34
2.46
female
0.05
0.41
2.65
Genera group popular in oral cavity
*3
%
all
0.18
1.4
9.74
[63, 65]
male
0.15
1.31
9.71
female
0.2
1.48
9.9
Fusobacterium
%
all
0
0
1.37
[59, 64]
male
0
0
2.92
female
0
0
0.83
Observed genera within class
Gammaproteobacteria
class
all
2
5
8
[59, 65]
male
2
5
8
female
2
5
8
*1: This index included Coprococcus, Roseburia,
Butyricicoccus, Faecalibacterium,
Anaerostipes, and Butyricimonas.
*2: This index included Lactobacillus,
Pediococcus, Leuconostoc,
Lactococcus, and Weissella.
*3: This index included Streptococcus,
Fusobacterium, and Enterobacter genera.
*1: This index included Coprococcus, Roseburia,
Butyricicoccus, Faecalibacterium,
Anaerostipes, and Butyricimonas.*2: This index included Lactobacillus,
Pediococcus, Leuconostoc,
Lactococcus, and Weissella.*3: This index included Streptococcus,
Fusobacterium, and Enterobacter genera.
DISCUSSION
We developed reference ranges using a large healthy Japanese cohort. The reference ranges
consider the effect of age, gender, diarrhea, and constipation to aid physicians with
accurate diagnosis of the intestinal bacterial composition ratio using a standard value
derived from a healthy population. Eighteen intestinal bacterial indicators suggested to be
associated with health status were selected. Using intestinal bacterial composition test
panels, the detection of intestinal bacterial indicators outside of their healthy ranges can
be useful evidence to support a medical plan.
Gut microbiota and sex/gender
Some characteristics of gender-specific immune differences are induced by gut microbiota.
Fransen et al. [48] investigated
significant gender differences in bacterial groups at the family or genus level. Females
had higher abundances of Desulfovibrionaceae,
Lactobacillaceae (Lactobacillus at the genus level),
and Verrucomicrobiaceae (Akkermansia at the genus
level), whereas males had higher abundances of Ruminococcaceae and
Rikenellaceae (Alistipes at the genus level). In this
study, several characteristic differences were observed between male and female subjects
regarding the abundances of gut microbiota at the genus level. The genera
Prevotella, Megamonas, Fusobacterium,
and Megasphaera were significantly abundant in male subjects, whereas
Bifidobacterium, Ruminococcus, and
Akkermansia were significantly abundant in female subjects. These
results are consistent with the results of previous Japanese studies [7, 33] and may be
considered as the characteristic gender differences in the composition of intestinal
microbiota in the Japanese population.
Gut microbiota and age/generation
Recent reports have shown a clear difference in the composition of the intestinal
microbiota of infants, adults, and the elderly [7,
8, 33]. The
microbiota composition initially shifts after birth, followed by significant shifts during
childhood and in later years [20]. In this study,
we segmented the population by age group (young, adult, and elderly group). Our results
are in agreement with studies indicating clear differences in gut microbiota composition
among infants, adults, and the elderly [7, 49, 50]. It was
found that the Actinobacteria abundance and alpha-diversity index were gut microbiome
indices related to aging. The most dramatic changes in gut microbiota diversity occur in
early childhood [20], but recent large
cross-sectional cohort studies have also reported increases in adulthood [7, 51]. In our
cross-sectional cohort, the alpha-diversity index showed slight increasing trend from 20
to 69 years old (Fig. 4) that was consistent
with recent previous reports [7, 51]. On the other hand, other recent studies have
suggested that both Bacteroides abundance and species diversity decline
in the feces of elderly subjects and that the abundance of
Bifidobacterium is reduced [27].
The gut microbiota composition of elderly subjects is expected to be in a state of flux
[20]. In our cross-sectional cohort, most elderly
individuals were community dwellers not in long-term residential care; this state of
healthy aging may maintain a high diversity of gut microbiota.
Gut microbiota and bowel habits (diarrhea/constipation)
Similarly to Vandeputte et al. [30], we found a significant association between bowel habits (stool shape and
defecation frequency) and gut microbiota diversity. Furthermore, deviations of the gut
microbiota composition in several genera, including Oscillospira,
Ruminococcus, Anaerotruncus,
Alistipes, and Akkermansia, in constipation subjects
and Fusobacterium and Dorea in diarrhea subjects were
confirmed, which is consistent with a previous report [33]. Although the role of these genera in stool consistency remains unclear, the
results illustrate the effect of gut microbiota on stool consistency in healthy Japanese
subjects.
Gut microbiota and racial/regional differences
Our results showed that Japanese adults (20–59 years old) had a greater abundance of the
genera Bacteroides and Faecalibacterium, interquartile
ranges (IQRs) of 27.43% (19.03–35.26) and 6.83% (3.39–10.06), respectively, and a
relatively lower abundance of the genera Clostridium (IQR 0.20%,
0.04–0.44), compared with previous studies in other Japanese cohorts [37]. However, the estimated abundances of
Bifidobacterium and Blautia were greater (IQRs of
2.47% (0.86–5.78), and 5.31% (2.94–7.85), respectively) than those of a previous study in
other nations (<0.5% and >5%, in the US and China, respectively) [37]. These bacterial compositions may be characteristic
of the intestinal microbiota of the Japanese population but may also reflect differences
in DNA extraction methods [52, 53] and the amplified region of the 16S rRNA [54].A high abundance of Bifidobacterium has also been observed in the gut
microbiome of Japanese children by 16S rRNA gene analysis [12], indicating its high prevalence throughout the Japanese population.
Bifidobacterium is thought to be a beneficial microbe that contains
more glycoside hydrolases for degrading starch than other intestinal microbes [55, 56].
Therefore, the high abundance of Bifidobacterium may be a consequence of
the intake of various saccharides in traditional and unique Japanese foods. However, it is
unknown which foods or nutrients contribute to the high abundance of
Bifidobacterium. As future prospects, it is essential to create a
reference microbiota for the Japanese population by age group and to increase the number
of subjects in the young and the elderly age groups. Additionally, investigations of
geographical differences within Japan are of interest.
Clinical relevance and reference ranges
All 11 microbiome indices successfully identified using 16S rRNA gene sequencing were
associated with specific health conditions. Alpha-diversity, including the Shannon index,
and observed genera number appeared to be associated with better health [57]. A recent meta-analysis proposed reduced
alpha-diversity as a reliable indicator of diarrhea-associated dysbiosis [58]. These microbiota diversity indices (Shannon index
and observed OTUs) revealed significant differences in the healthy aging group, indicating
that a healthy, diverse diet promotes greater diversity in the gut microbiota [57].Previous studies have proposed that Bifidobacterium is inversely
associated with inflammatory bowel disease (IBD) and diarrhea-associated dysbiosis [59] and the consumption of probiotics, inulin, and
oligofructoses promotes an increase in Bifidobacterium abundance [60]. Additionally, Faecalibacterium
has been proposed to be a dominant member of the human intestinal microbiota in healthy
adults and especially to be a health sensor for active Crohn’s disease patients [61]. A recent meta-analysis showed a reduction in
butyrate-producing Clostridiales, including Coprococcus,
Roseburia, Butyricicoccus,
Faecalibacterium, Anaerostipes, and
Butyricimonas, which are associated with a healthy gut [59].Although not all genera within the order Lactobacillales are verified
lactic acid producers, the dominant genera within this order (including
Lactobacillus, Pediococcus,
Leuconostoc, Lactococcus, and
Weissella) are known to harbor genes for lactic acid production and are
often enriched in the case of patients across multiple diseases [58]. Lactobacillales genera have been shown to adapt
to the lower pH of the upper gastrointestinal tract [62]. Thus, the shared disease-associated taxa may be indicators of shorter stool
transit times and disruptions in the redox state and/or pH of the lower intestine, rather
than specific pathogens. Genera within Lactobacillaceae and
Streptococcaceae families are dominant in the upper gastrointestinal
tract and are present in the stool of many individuals at low frequency [58]. These taxa likely become enriched with faster
stool transit time (i.e., a diarrhea signature) [58].Previous studies have proposed Fusobacterium to be associated with various human diseases
[63]. Dysbiosis associated with colorectal cancer
is generally characterized by increased prevalence of known pathogenic or
pathogen-associated Fusobacterium and Enterobacter
genera, which were shown to be higher in colorectal cancerpatients in two or more studies
[58]. Furthermore, other oral community genera,
such as members of Porphyromonas, Peptostreptococcus,
and Parvimonas, were found with Fusobacterium on colonic
tumors [64].
Limitations
We concede that this study has several limitations. First, this research was a
participatory observational study. This kind of study may be self-selecting and have a
tendency for illness behaviors, which may create a biased cohort rather than a true
representation of the Japanese population [65]. As
shown in Supplementary Table 1, the study cohort contained mostly females in their 30s and
40s, followed by males in their 30s and 40s. In addition, as shown in Table 3, in the cohort of the adult (20–59) age group, 50% or
more of individuals in the group answered that they had diarrhea or constipation, a higher
prevalence than in the general Japanese population. On the other hand, we believe that it
was possible to adjust for these biases by screening the analysis dataset as shown in
Supplementary Fig. 1. We excluded individuals with a medical history, the elderly, the
young, and those with diarrhea/constipation symptoms to extract the reference value
population. We did not exclude obese individuals from our reference dataset because Japan
has one of the lowest rates of prevalence of obesity (about 4–4.5% of the adult
population) in the world [66], and the obese
population (BMI >30) in our healthy reference dataset was even lower (3.8% for men,
3.5% for women). Therefore, we believe they did not make a strong impact on the reference
range values. However, it might be better to reconsider adding the BMI criterion for a
more rigorous definition of “healthy” in future studies. Second, the scope of the present
study did not extend to analysis of the influence of medication such as antibiotics on the
gut microbiota profile, thus representing a qualitative limitation.
CONCLUSION
Regardless of health status, there are many microorganisms that are clinically related to
health and disease in the intestines of all people, and the exquisite balance of these
microorganisms varies greatly from person to person, making the definition of “good flora”
difficult. However, to understand and monitor the health and balance of an individual’s gut
microbiota, it is essential to first know the reference ranges available from a large,
healthy population such as the one presented here. By further expanding the cohort of
healthy subjects and accumulating a cohort of various health conditions and attributes, more
valuable indicators can be identified, leading to the realization of personalized precision
medicine using microbiome information in the future.
DATA AVAILABILITY
Requests for materials and/or data should be addressed to the corresponding author, SW.